Search results for "vaccine" in Articles / App Notes
Article
Fluid Handling in Biopharma Facilities
For example, flexibility is key in the case of manufacturing facilities that have to deal with multi-products for seasonal vaccines or pandemic response vaccines.
Hutchinson (Parker domnick hunter…
Article
Detecting Protein Aggregates and Evaluating their Immunogenicity
(2) on forced degradation studies in vaccines have helped evaluate the propensity of a product to aggregate at various points in the manufacturing process.
Higher concentrations of a protein formu…
Article
Concentration and Diafiltration of Cell-Derived, Live Influenza Virus Using 750 C Hollow Fiber Filter Cartridge
Cross flow filtration (CFF) is a technique extensively used in vaccine production and particularly in influenza vaccine manufacturing. In contrast to normal flow (dead-end) filtration (NFF), the fee…
Article
Advances in Sterilization Technologies for Overcoming Viral-Vector Manufacturing Challenges
Scaling considerations
Scaling itself does not necessarily increase the risk of losing sterility during viral-vector manufacturing, particularly for high-volume, low-titer products such as vaccines…
Article
Discussing the Origins of the mRNA Therapeutics Field
Andy Geall, co-founder and chief development officer at Replicate Bioscience, discusses the historical context and buildup of the mRNA therapeutics field.
Watch video
Article
Top Process Development Trends for 2022 and a Look into 2023
In parallel, brought on by the obvious commercial success of the warp speed program for COVID-19 vaccines, came a need for reduced timelines, which accelerated the ongoing Industry 4:0 analytics, digi…
Article
Reducing the Risk of RNAse Contamination in mRNA Production
As drug and vaccine manufacturers work to optimize mRNA production processes, one hurdle to overcome is mRNA’s susceptibility to breakdown by ribonuclease (RNase) enzymes introduced during p…
Article
Report from the 12th Plasma Product Biotechnology Forum
Even after the availability of new vaccines and relaxed restrictions, the plasma donations did not return to pre-pandemic levels. Hence, FDA revised recommendations for certain donor deferrals based o…
Article
PEPTalk Event
Visit us at the PepTalk conference in San Diego. Attend our talk, powerpoint presentations, and panel discussions to learn the latest in protein science.
LEARN MORE >> …
Article
Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing
…laboration to speed biomedical research efforts and to ensure broad access to quality medicines and vaccines.
Read More >>